by Jessica Etheridge | Sep 20, 2023 | CROs, Laboratory, Product Pipeline, Uncategorized
Introduction The development and commercialization of diagnostic devices are a complex endeavor that involves a multitude of steps, from the initial conceptualization to market launch and post-market surveillance. Given the critical role diagnostic devices play in...
by Jessica Etheridge | Apr 25, 2023 | ColoPlex, Product Pipeline
ColoPlex Biomarker Data Published in Journal of Clinical Oncology Novel blood-based biomarker candidates in screening for colorectal cancer. Jason Lee Liggett, Mathias M Petersen, Jakob Kleif, Morten Rasmussen, Lars Nannestad Jørgensen, Jakob Benedict Seidelin, Mogens...
by Jessica Etheridge | Nov 1, 2021 | ColoPlex, Colorectal Cancer, Product Pipeline
Luminex Licensed Technologies Partner Spotlight: EDP Biotech Early detection makes a real difference in outcomes for cancer patients. But for cases of colorectal cancer, detecting tumors in the earliest stages has been virtually impossible. The team at EDP Biotech is...
by Jessica Etheridge | Sep 1, 2015 | ColoPlex, Product Pipeline
Knoxville, Tenn. – (August 31, 2015) – EDP Biotech Corporation, (EDP), a global in vitro diagnostic innovator of simple, blood-based cancer diagnostic tests, announces the publication of key study data for its ColoMarkerÒ ELISA kit. In this clinical research study,...
by Jessica Etheridge | Jul 10, 2015 | ColoPlex, Product Pipeline
The primary objective of this study was to determine the correlation between elevated levels of the CA 11-19 tumor marker in blood and the presence of colorectal cancer or pre-cancer. Download the Study
by Jessica Etheridge | Mar 31, 2015 | ColoPlex, Product Pipeline
March 31 2015 EDP Biotech Signs Distribution Partnership Agreements for ColoMarker® Abroad ColoMarker®is a simple, sensitive blood test that aids in detection of earlystage colorectalcancer. Knoxville, Tenn. – (March 31, 2015) – EDP Biotech Corporation (EDP), a...
